Suda T, Takahashi M, Katayama Y, Soga K, Kobori I, Kusano Y, Tamano M. Progress of ulcerative colitis patients during the COVID-19 pandemic. World J Clin Cases 2023; 11(23): 5462-5467 [PMID: 37637693 DOI: 10.12998/wjcc.v11.i23.5462]
Corresponding Author of This Article
Toshikuni Suda, Doctor, MD, PhD, Doctor, Instructor, Staff Physician, Division of Gastroenterology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya-Shi, Saitama 343-8555, Japan. toshikuni.suda@gmail.com
Research Domain of This Article
Medicine, Research & Experimental
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Toshikuni Suda, Yasumi Katayama, Koichi Soga, Ikuhiro Kobori, Yumi Kusano, Masaya Tamano, Division of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan
Morio Takahashi, Division of Gastroenterology, Morio Clinic, Saitama 343-0808, Japan
Author contributions: Suda T recruited patients and wrote the paper; Takahashi M designed the study and analyzed data; Soga K revised the manuscript; Kobori I and Kusano Y provided clinical advice; and Tamano M and Katayama Y supervised the study.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of Dokkyo Medical University Saitama Medical Center (Approval No. 20100).
Informed consent statement: All patients provided informed consent to participate in this study and agreed to publication of the research results.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Toshikuni Suda, Doctor, MD, PhD, Doctor, Instructor, Staff Physician, Division of Gastroenterology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya-Shi, Saitama 343-8555, Japan. toshikuni.suda@gmail.com
Received: May 24, 2023 Peer-review started: May 24, 2023 First decision: June 20, 2023 Revised: June 30, 2023 Accepted: July 25, 2023 Article in press: July 25, 2023 Published online: August 16, 2023
ARTICLE HIGHLIGHTS
Research background
Previously, we reported that patients with ulcerative colitis (UC) had the worst symptoms during the coronavirus disease 2019 (COVID-19) pandemic.
Research motivation
The COVID-19 pandemic continued in 2021 and 2022.
Research objectives
We investigated whether people with UC had changes in symptoms in 2021 and 2022.
Research methods
Patients with UC included in previous studies were compared using UC-disease activity index (UC-DAI) and the Matts grade score.
Research results
Both UC-DAI and Matts grade scores fell from 2020 to 2021 and did not rise in 2022.
Research conclusions
Patients with UC experienced stress and worsened their symptoms in 2020 during the COVID-19 pandemic. The virus epidemic continued in 2021 and 2022, but the symptoms did not worsen.
Research perspectives
Since the symptoms of patients with UC are significantly worsened by stress, doctors need to pay attention to the worsening of symptoms of patients with ulcreative colitis when a major disaster occurs in the future.
